Diagnosis | GW | Associated cardiac anomaly | Outcome | |||
---|---|---|---|---|---|---|
19–31 | 32–36 | TOP | IFUD | NNA | ||
Physiological | 52 | 150 | TR (101) | 0 | 0 | 202 |
Volume overload | ||||||
R-FO | 3 | 48 | HLHS (9); PV-S (5)a; TR (21) | 9 | 0 | 42 |
Tricuspid dysplasia | 28 | 15 | VSD (3); PE (14); TR (43) | 2 | 0 | 41 |
Ebstein’s anomaly | 13 | 3 | PV-S (4)a; PV-A(3)b; VSD(4); TCA(2); PE(2); TR(16) | 5 | 0 | 11 |
Tricuspid atresia | 9 | 0 | VSD (5); PV-S (5)a; HRHS(7); PE(3) | 6 | 0 | 3 |
TAPVC | 16 | 3 | VSD (5); PLSVC (3) | 2 | 1 | 16 |
Galen aneurysm | 2 | 2 | Ascites (4); SUA (2) | 0 | 0 | 4 |
Pressure overload | ||||||
Pulmonary stenosis | 32 | 12 | VSD (8); PE (6); PLSVC (2); TR (35) | 2 | 0 | 42 |
Pulmonary atresia | 13 | 0 | VSD (5); DORV (2); HRHS (4); PE (2); TR (8) | 4 | 0 | 9 |
Ductus closure | 2 | 7 | VSD (3); RAA (2); PE (3); TR(9) | 2 | 0 | 7 |
Ductus contraction | 3 | 7 | TR (10) | 0 | 0 | 10 |